Melphalan
Back to searchMolecule Structure
Scientific Name
Melphalan
Description of the Drug
Melphalan is an alkylating antineoplastic agent used for high-dose conditioning prior to hematopoietic stem cell transplant in patients with multiple myeloma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01042
http://www.drugbank.ca/drugs/DB01042
Brand Name(s)
Aikeran, Alkeran
Company Owner(s)
Apotex Inc, Fresenius Kabi Usa Llc, Ingenus Pharmaceuticals Llc, Sagent Pharmaceuticals Inc, Bpi Labs Llc, Alvogen Inc, Par Sterile Products Llc, Nanjing Noratech Pharmaceutical Co Ltd, Gland Pharma Ltd, Uswm Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5872 | |||
| Human Metabolome Database | HMDB0015176 | |||
| DrugBank | DB01042 | |||
| PubChem: Thomson Pharma | 14874007 | 14898602 | ||
| PubChem | 6918992 | 460612 | ||
| Mcule | MCULE-8007157187 | |||
| Nikkaji | J2.962I | |||
| BindingDB | 50025837 | |||
| EPA CompTox Dashboard | DTXSID6020804 | |||
| DrugCentral | 1678 | |||
| Metabolights | MTBLC28876 | |||
| Brenda | 135393 | |||
| ChemicalBook | CB2492687 | |||
| Guide to Pharmacology | 7620 | |||
| rxnorm | MELPHALAN HYDROCHLORIDE | ALKERAN | EVOMELA | MELPHALAN |
| KEGG Ligand | C07122 | |||
| ChEBI | 28876 | |||
| ZINC | ZINC000000001673 |
